|
glioblastoma |
10 |
|
glioma |
7 |
|
prognosis |
6 |
|
temozolomide |
6 |
|
c6 glioma |
5 |
|
diffusion weighting |
5 |
|
lactate |
5 |
|
lipid |
5 |
|
magnetic resonance spectroscopy |
5 |
|
molecular size |
5 |
|
spectral overlapping |
5 |
|
apoptosis |
4 |
|
biomarkers |
4 |
|
chemoresistance |
4 |
|
glioblastoma multiforme |
4 |
|
inflammation |
4 |
|
lncrnas |
4 |
|
metabolic reprogramming |
4 |
|
mgmt |
4 |
|
neuroprotection |
4 |
|
p4hb |
4 |
|
surgical brain injury |
4 |
|
brain oedema |
3 |
|
dexamethasone |
3 |
|
differentiation |
3 |
|
fibrin sealant |
3 |
|
glioblastoma stem cell |
3 |
|
hemostasis |
3 |
|
lncrna |
3 |
|
matrix metalloproteinase 9 |
3 |
|
mirna |
3 |
|
myelination |
3 |
|
nanomaterial |
3 |
|
oligodendrocyte |
3 |
|
progesterone |
3 |
|
rada16-i |
3 |
|
sapns |
3 |
|
spinal cord injury |
3 |
|
vitamin d |
3 |
|
actin cytoskeleton |
2 |
|
add3 |
2 |
|
adducin |
2 |
|
autophagy |
2 |
|
biomarker |
2 |
|
blood–brain barrier |
2 |
|
brain metastasis |
2 |
|
cancer metabolism |
2 |
|
cell apoptosis |
2 |
|
cell growth |
2 |
|
cell-matrix interaction |
2 |
|
cerebral hemorrhage |
2 |
|
crnde |
2 |
|
cytoskeletal proteins |
2 |
|
deletion mapping |
2 |
|
endoplasmic reticulum stress |
2 |
|
er stress |
2 |
|
er stress reponse |
2 |
|
er stress response |
2 |
|
gbm |
2 |
|
gliomagenesis |
2 |
|
gliosarcoma |
2 |
|
h19 |
2 |
|
hormones |
2 |
|
hotair |
2 |
|
hyperoxia |
2 |
|
idh1 mutation |
2 |
|
intracerebral haemorrhage |
2 |
|
lncrna-mirna interaction |
2 |
|
lncrna-protein interaction |
2 |
|
long non-coding rna |
2 |
|
loss of heterozygosity |
2 |
|
macrophages |
2 |
|
meg3 |
2 |
|
metabolism |
2 |
|
metabolomics |
2 |
|
metastasis-initiating cells |
2 |
|
mgmt promoter methylation |
2 |
|
monocytes |
2 |
|
neuroinflammation |
2 |
|
neuroplasticity |
2 |
|
neutrophil extracellular traps |
2 |
|
non-metabolic |
2 |
|
non-small cell lung cancer |
2 |
|
patient-derived xenograft |
2 |
|
primary culture |
2 |
|
prolyl 4‑hydroxylase beta polypeptide |
2 |
|
pyroptosis |
2 |
|
regional hypothermia |
2 |
|
rna interference |
2 |
|
rutin |
2 |
|
secondary gliosarcoma |
2 |
|
signal pathway |
2 |
|
sirt5 |
2 |
|
sirtuin |
2 |
|
surgical spinal cord injury |
2 |
|
synapse modulation |
2 |
|
transcript variant |
2 |
|
transcription factor |
2 |
|
tumor suppressor |
2 |
|
vascular endothelial growth factor |
2 |
|
vitamin d deficiency |
2 |
|
biomolecular condensate |
1 |
|
fusion oncoprotein |
1 |
|
hippo signaling |
1 |
|
phase separation |
1 |
|
tumorigenesis |
1 |
